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ABSTRACT. Recent discoveries on non coding RNAs (ncRNAs) suggest that a huge number
of regulative mechanisms of transcription and translation in eukaryotes could represent the
key to improve our knowledge on many diseases etiopathogenesis, like Retinitis pigmentosa
(RP). Among ncRNAs, small nucleolar RNAs (snoRNAs), and their sub - group Small Cajal
Body - specific RNAs (scaRNAs), represent an undiscovered world. We compared snoRNAs
expression changes, coming from whole transcriptomes analyses, between two group of
Retinal Pigment Epithelial (RPE) cells, treated with the oxidant agent oxidized low-density
lipoprotein (oxLDL) and untreated, respectively, considering four time points (1h, 2h, 4h,
6h). We found 84 snoRNAs, clustered in five groups based on showed altered expressions in
treated samples and targeting several ribosomal RNAs (rRNAs), presented their host genes
involved in several biochemical pathways. One of them, involving the “silencing activity
mediated by the interferon-γ-activated inhibitor of translation (GAIT) translational control
system”, seems to be very interesting and only speculated to be associated to RP. SnoRNA
expression analysis of oxidative stress induced RPE cells suggested that ncRNAs could play
a relevant role in RP etiopathogenesis, regulating pathways directly or indirectly related to
the considered disease.
1. Introduction
Recent discoveries on non coding RNAs (ncRNAs) suggest that a huge number of
regulative mechanisms of transcription, maturation (e. g. splicing, (Scimone et al. 2017)
and translation in eukaryotes could represent the key to improve our knowledge on many
diseases etiopathogenesis (Santosh et al. 2015). In eukaryotes, the ribosomal RNA (rRNA)
requires several site-specific post-transcriptional nucleotide modifications, most relevant of
which are represented by the addition of a methyl group to the 2’-hydroxyl group of a ribose
residue (2’-O-methylation) and the isomerization of uridine to pseudouridine (Ψ), a reaction
known as pseudouridylation (Arai et al. 2013). Both processes occur in the nucleolus and
involve a huge number of small nucleolar RNAs (snoRNAs), made of 60-300 nucleotides,
as well as multicomponent complexes, constituted by small nucleolar ribonucleoprotein
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(snoRNP) (McMahon et al. 2015). SnoRNAs can be divided into two classes which possess
distinctive sequence elements: the highly conserved box C/D snoRNAs promote the 2’-O-
methylation of specific sites on rRNA, thanks to the methyltransferase fibrillarin (Scott et al.
2012). The second group, represented by the box H/ACA snoRNAs, guide pseudouridine
modifications at specific sites on rRNA, with the help of the pseudouridine synthase dyskeri
and several additional proteins like GAR1 and NOP10 (Watkins and Bohnsack 2012).
Interestingly, there is a growing evidence that guide snoRNA targets are not limited to
rRNA, as evidenced by identification of many “orphan snoRNAs” with already unknown
target RNAs (Dupuis-Sandoval et al. 2015). Even if the exact function of different types
of rRNA modifications is not totally clear, there is now a mounting hypothesis that the
machinery needed for site-specific rRNA modifications is required for normal development
and is altered in numerous human pathologies, as cancer, neurodegenerative and genetic
diseases (Stepanov et al. 2015). Retinitis pigmentosa is a genetic disease characterized by
retinal degeneration and followed by a slow and progressive death of photoreceptors and
retinal pigment epithelium (RPE) cells, leading to impairment of visual neurotransmission
(Natarajan 2013). The term “pigmentosa” deals with the typical appearance, during the
advanced states of the disease, of abnormal areas of pigment into the back portion of
the eye (Zhang 2016). Many evidences support the role of snoRNAs in normal retinal
development and functions, but exact mechanisms are still unknown (Liu et al. 2016).
Moreover, snoRNAs expression data come only from the analysis of murine small non
coding RNAs but, due to structural and functional differences between human and mouse
retinas, they are not totally useful (Soundara Pandi et al. 2013). Therefore, an improved
knowledge of human retina snoRNAs, especially of patients affected by retinal disease,
could lead to better understanding the unappreciated functional role of snoRNAs related
to physiopathology of this tissue. In our work, we studied the complexity of human retina
snoRNAs, analyzing data from human retinal pigment epithelium (RPE) cells transcriptomes.
RPE is made of a single layer of cells playing a key role in maintenance, regulation and
protection of the photoreceptor layer (Strauss 1995). Due to its specific proteins, RPE
regulates the trafficking of nutrients and waste products to and from the retina, help to renew
outer segments by phagocytizing the spent discs of photoreceptor outer segments, protects
the outer retina from excessive high-energy light and light-generated oxygen reactive species
(ROS) and maintains retinal homeostasis through the release of diffusible factors (Amram
et al. 2017). In details, we compared snoRNAs expression changes between two group of
RPE cells, treated with the oxidant agent oxidized low-density lipoprotein (oxLDL) and
untreated, respectively, considering four time points (1h, 2h, 4h, 6h) over basal one (time
zero). oxLDL was selected due to its known involvement in neurodegenerative diseases
pathogenesis but, especially, because it is well known that high cholesterol level could be
linked to RP development (Rodriguez and Larrayoz 2010). Main purpose of our work was
to discover which snoRNAs changed during oxidative stress induction and which are their
targets, in order to better understand how ROS might lead to RP development.
2. Materials and Methods
This study was approved by the Ethics Committee of Azienda Policlinico Universitario
“G. Martino” Messina.
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2.1. Cell culture. Human RPE-derived Cells (H-RPE - Human Retinal Pigment Epithelial
Cells, CloneticsTM, Lonza) were maintained at 1x106 cellsml culture in RtEGM
TM Retinal
Pigment Epithelial Cell Growth Medium BulletKitr (CloneticsTM, Lonza) with 2% FBS,
100 unitsml of penicillin and 100
µg
ml of streptomycin and incubated at 37
◦ C with 5% CO2.
Finally, 100 µgml of oxLDL was added to the treated group, after 24 hours.
2.2. Total RNA sequencing. RNA was extracted by TRIzolTM Reagent (InvitrogenTM,
ThermoFisher Scientific), following manufacturer’s protocol, and quantified at Qubit 2.0
fluorimeter by Qubitr RNA assay kit (Invitrogen, Life Technologies). Expression analysis
compared the transcriptome of Human RPE cells treated with 100 µgml of oxLDL with
untreated ones, both at time zero and at four following different time points (1h, 2h, 4h,
6h). Libraries were generated using 1µg of total RNA and the Ion Total RNA-Seq Kit v2
(ThermoFisher Scientific), then purified by Dynabeadsr Magnetic Beads and quantified
at Qubitr 2.0 fluorimeter with Qubitr dsDNA HS Assay Kit. Specific libraries amount
was used for clonal amplification realized with Ion PITM Template OT2 200 Kit v2 (Ther-
moFisher Scientific) on Ion One TouchTM 2 System; template-positive Ion Sphere Particles
were enriched at Ion One TouchTM Enrichment System. Sequencing runs were performed
on an Ion ProtonTM Sequencer (Ion Torrent technology, ThermoFisher Scientific), using the
Ion PITM Sequencing 200 Kit v2 and the Ion PITM Chip Kit v2 (ThermoFisher Scientific).
The experiment was thrice repeated.
2.3. Quality data validation and real mapping. Sequence reads were generated from
RPE specific cDNA libraries on the Ion Torrent Proton. Low quality, ambiguous and con-
taining adaptor reads (average per base Phred score < 28) were removed from obtained raw
data. The quality of analyzed data was checked using the FastQC (v.0.11.5) and QualiMap
(v.2.2.1) software. The filtered data was, then, analyzed by CLC Genomics Workbench
v.10.1.1 (https://www.qiagenbioinformatics.com/products/clc-genomics-workbench/) using
Homo sapiens genome hg19 and Ensembl RNA database v.74 as references. RNA - Seq
analysis was conducted using the following settings: quality trim limit = 0.02, ambigu-
ity trim maximum value=2. Map to annotated reference: minimum length fraction and
minimum similarity fraction=0.7, maximum number of hits/read=2, type of organism =
eukaryote, paired settings = default.
2.4. Small RNA Analysis. The applied approach evaluated the different types of small
RNAs in the data and compared them to selected databases of small RNAs. Once imported
whole RNA - Seq data, the small RNAs were extracted and counted, in order to create a small
RNA sample that could be used for further steps. Sequences were filtered basing on length
(reads below 60 bp and above 300 bp were discarded) and on minimum sampling count (set
at 1). Subsequently, the number of reads mapping on each snoRNA was counted and, then,
normalized using either the Trimmed Mean of M-values (TMM) method (Robinson and
Oshlack 2010) or reads per million (CPM). Finally, the snoRNA sample produced when
counting the tags was, then, enriched by comparing the tag sequences with the annotation
resources Ensembl non -coding RNA database (v.74) (Zerbino et al. 2016), Genecode
Release 27 (Harrow et al. 2012) and Database of small human noncoding RNAs (DASHR)
(Leung et al. 2016).
Atti Accad. Pelorit. Pericol. Cl. Sci. Fis. Mat. Nat., Vol. 96, No. S3, A7 (2018) [12 pages]
RE
TR
AC
ED
A7-4 L. DONATO ET AL.
2.5. Gene expression and statistical analysis. The original expression values were log2
transformed and normalized in order to ensure that samples are comparable and assumptions
on the data for analysis are met (Feng et al. 2014). In order to highlight the snoRNAs
with different expression levels between untreated and treated samples, and during four
analyzed time points, we classified them into two groups, based on count ratios (fold -
change): 1) Up - regulated (fold - change >1); 2) Down - regulated (0< fold - change
<1). Moreover, due to fold - changes linearity, we chose to replace any value smaller
than 1 (i. e. for downregulation) with its negative reciprocal one, in order to make the
variation more noticeable (for instance, 2-fold downregulation is indicated by a value of
-2 instead of 0.5). Due to a limited availability of biological replicates for each of the
experimental group studied (only 3 replicates for each selected time point), but with many
features to be analyzed simultaneously (snoRNAs in a whole transcriptome), we applied
the Empirical analysis of DGE (EDGE) statistical algorithm, which implements the “Exact
Test” for two-group comparisons developed by Robinson and Smyth (Robinson and Smyth
2008). The test assumes that the count data follows a Negative Binomial distribution,
and not the Poisson one, allowing for a non-constant mean-variance relationship. The
“Exact Test” of Robinson and Smyth is similar to Fisher’s Exact Test, but also accounts
for overdispersion caused by biological variability. The snoRNAs uniquely identified in
the RPE cells with at least 6 unique gene reads, greater than one-fold (up-regulated) or
lower than one-fold (down-regulated) changes in expression based on expression values
ratio, and with Bonferroni - adjusted p-values lower than 0.05, were selected for functional
categorization of differentially expressed snoRNAs.
2.6. snoRNA target identification and host genes pathway analysis. Obtained snoR-
NAs were firstly analyzed by the experimentally validated snoRNAs database snoRNABase
(Lestrade and Weber 2006), and then investigated by snoRNA Orthological Gene Database
snOPY (Yoshihama et al. 2013) web - based archive and by Ingenuity Target Explorer
(QIAGEN, Inc., https://targetexplorer.ingenuity.com/), in order to define specific targets and
host genes. Once obtained them, a pathway analysis of selected host genes was performed
by Cytoscape and its plug - in ClueGO (Bindea et al. 2009).
3. Results
3.1. Sequencing analysis and mapping statistics. RNA sequencing carried out on Ion
Torrent yielded a total of 11,214,300 quality reads (mean mapping quality=32,92) with
mean read length of 155.03 bp. All reads were previously aligned to GRCh37/hg19
reference assembly, and then to known small human noncoding RNAs (DASHR) and
GRCh37 non - coding RNAs (ncRNAs). About 71,500 Small RNAs were founded in all
samples, 69,158 of which annotated and about 2,341 unannotated. In details, 84 snoRNAs,
resulted from mapping, showed expression alterations in analyzed time points (see Table
1 in Supplementary Files, separately available on the article’s web page). All previous
mapping statistics are based on average values calculated for all three replicates in each
time point.
3.2. Expression analysis. The mean length of resulted snoRNAs was 129.6 bp for snoR-
NAs, with an average value of 354 bp for scaRNAs. We identified a total of 84 snoRNAs
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with an average expression level of 23.615 reads across all considered treated and untreated
RPE cells cultures. The variability was significant across samples, with an expected lower
trend for expressed scaRNAs. There is a specific fold - change range during analyzed time
points, with the highest value of 9.583 reached by SNORD55 and the lowest of -8.361
expressed by SNORD110. Interestingly, we found seven clusters of snoRNAs showing
interesting trends through analyzed time points: Cluster 1, showing the highest number
(26) of deregulated snoRNAs, evidenced a global increase of expression in treated samples
(average fold - change = 2.169). Cluster 2, made of 17 snoRNAs, evidenced a huge decrease
(average fold - change = -0.915) in treated samples through all selected time points. Cluster
3, represented by 14 snoRNAs, and Cluster 4, made of 12 elements, highlighted only one
variation during a single time point, with a positive value of fold - change (average fold -
change = 0.768) and a negative one (average fold - change = -0.603), respectively. Cluster 5
and Cluster 6, made of 5 snoRNAs each other, showed a curious trend similar to the last two
previously described ones, but with two down - regulations (fold - change = -1.949) or two
up - regulations (average fold - change = 1.539) through all selected time points. Finally,
Cluster 7, made of 4 snoRNAs, resulted up - regulated in 50% of time points and down -
regulated in the other 50% (average fold - change = 0.084). Only SNORD69 showed no
expression changes during the experiment. Detailed expression data are available in Figure
1 and in Table 2 of Supplementary Files (separately available on the article’s web page).
3.3. snoRNAs target identification and host genes pathway analysis. Sixty-eight dif-
ferent residues of ribosomal RNAs resulted as targets of 84 found altered snoRNAs in
snoRNABase, snOPY and Ingenuity Target Explorer. Specific targets of 5 H/ACA box
snoRNAs (SNORA18, SNORA53, SNORA59A, SNORA59B, SNORA11D) and of 10
C/D box snoRNAs (SNORD23, SNORD89, SNORD109B, SNORD116-24, SNORD116-
6, SNORD116-8, SNORD22, SNORD83A, SNORD83B, SNORD84) resulted, instead,
still unknown. Detailed report of all analyzed snoRNAs targets is available in Table 2.
Afterwards, 6 “macro - pathways” (“L-13-mediated translational silencing of Ceruloplas-
min expression”, “Cytoplasmic translation”, “RNA helicase activity”, “Dissociation of
L13a from the 60S ribosomal subunit”, “eIF3 and eIF1A bind to the 40S subunit” and
“Association of phosphor-L13a with GAIT element of Ceruloplasmin mRNA”) (Figure
2) and 125 “sub - pathways” resulted from host genes pathway analysis (see Table 3 in
Supplementary Files, separately available on the article’s web page).
4. Discussion
In the wide world of genetic pathologies, little is known about regulative non - coding
RNAs involvement (D’Angelo et al. 2012; Adams et al. 2017). The only validated knowl-
edge regards miRNA role (D’Angelo et al. 2013), which opened new frontiers about 3’
UTR and intron variants involvement into etiopathogenesis of such pathologies (Scimone
et al. 2015), giving ncRNAs the status of most promising targets of experimental therapies
(Guzman-Aranguez et al. 2013). Among them, Retinitis pigmentosa, an ocular disease with
very heterogeneous phenotypes, shows unusually complex molecular genetic causes, most
of which still unknown (D’Angelo et al. 2017). Using deep sequencing technologies, we
analyzed the whole transcriptome of RPE cells, exposed to ox-LDL, during a follow-up of
four time points (1h, 2h, 4h and 6h) after exposure, and compared to untreated ones. Thanks
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FIGURE 1. Circular plot made by CIRCOS (http://circos.ca) highlighting fold –
changes of all analyzed snoRNA during selected time points in each concentric
circle. Larger width means greater fold – change. Fold – change 1. 0h vs 1h
– Treated. 2. 1h (Treated vs Untreated). 3. 2h (Treated vs Untreated). 4. 4h
(Treated vs Untreated). 5. 6h (Treated vs Untreated).
to the high coverage of our sequencing experiment, along with parallel analysis of three
replicates for each selected group for each time point, we obtained reliable data, overcoming
possible bias - related variability in snoRNA expression levels and nucleotide sequences.
Oxidative stress plays a critical role in the etiopathogenesis of RP (Campochiaro et al. 2015),
especially targeting RPE cells, very sensible because of high metabolic demand, needed
for processes like physiological phagocytosis and life-long light illumination. Impairment
of such functions could lead to pathobiological modifications like outer blood-retinal bar-
rier (BRB) dysfunctions, alterations of extracellular matrix (ECM) components, inhibition
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FIGURE 2. ClueGO pathway analysis of snoRNAs host genes from snoRNABase
and snOPY. ClueGO analysis highlighted a rich and very clustered network of
possible involved pathways for both snoRNABase and snOPY host genes for
selected snoRNAs. Details are available in Table 3.
of photoreceptors outer segments processing, increasing of RPE cells senescence and/or
apoptosis (Mitter et al. 2014). Moreover, several snoRNAs were already detected in murine
retina, suggesting a possible involvement in retinal development and activity (Liu et al.
2016). Although how such functions could be explicated need to be yet totally understood,
several evidences highlight snoRNAs role in influencing translational fidelity, stop codon
recognition and ribosome - ligand interactions (Wilusz and Wilusz 2014). Additionally,
snoRNAs could play a fundamental role in chromatin remodeling, in miRNA - like post -
transcriptional gene silencing and in lncRNA - like RNA splicing modulation (McMahon
et al. 2015). Intriguingly, the most interesting snoRNAs research area regards the ability
for pseudouridine in nonsense codon suppression, potentially altering the coding potential
of non-canonical RNA substrates, such as mRNAs (Weischenfeldt et al. 2005). For this
purpose, we realized a pathway analysis of snoRNAs host genes to highlight possible
involvement in Retinitis pigmentosa pathology. Host gene pathway analysis evidenced
that alteration of found snoRNAs expression could impair the interferon-γ-activated in-
hibitor of translation (GAIT) translational control system, made of glutamyl-prolyl tRNA
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synthetase (EPRS), NS1-associated protein 1 (NSAP1), ribosomal protein L13a (L13a),
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Mukhopadhyay et al. 2009). It
controls the transcript - selective translation of functionally related genes, binding structural
GAIT elements in the 3’-untranslated regions (UTRs) of multiple inflammation - related
mRNAs, including ceruloplasmin (Cp), and represses their translation (Fox 2015). Cerulo-
plasmin is a multifunctional, copper-binding α -globulin, with antioxidant capabilities, due
to the discharge of electrons, e.g. during conversion of Fe(II) to Fe(III) (Eid et al. 2014). In
our analysis, we have seen interestingly changes in pathways involving L13a, an integral
constituent of the ribosome 60S subunit (Eid et al. 2014). In details, it was highlighted
a possible alteration in dissociation of L13a from the 60S ribosomal subunit, following
DAPK-ZIPK kinase axis phosphorylation, and an association of phospho-L13a with GAIT
element of ceruloplasmin, with the possible block of eIF3-containing 43S pre-initiation
complex, thereby promoting the L-13a-mediated translational silencing of ceruloplasmin ex-
pression. RPL13A mRNA is co - transcribed with four box C/D snoRNA genes, U32a, U33,
U34 and U35a, located within four RPL13A introns (Michel et al. 2011), and globally down
- expressed in our data. Such results could be compatible with alterations in ceruloplasmin
levels, influencing both the transport of copper and the functioning of RPE (Hadziahmetovic
et al. 2008), as seen in Indian patients of RP (Gahlot et al. 1976) and macular degenera-
tion (Newsome et al. 1986). Additionally, alterations of copper metabolism could impair
allosteric effects on reducing misfolded aggregates, as in other neurodegenerative disorders
including Alzheimer disease (Pal et al. 2014). Moreover, DAPK and ZIPK are validated
regulators of programmed cell death pathways, suggesting the possibility that GAIT - me-
diated translational repression of the kinases could contribute to regulation of apoptosis.
Additionally, it was seen that GAIT complex assembly is inhibited by ox - LDL, resulting
in sustained production and accumulation of GAIT system target proteins like Cp (Arif
et al. 2017). Moreover, deletion of the Rpl13a snoRNA in a mouse model, while leaving
the coding and regulatory regions intact, profoundly influenced mitochondrial metabolism,
resulting in enhanced systemic glucose tolerance and protection against oxidative stress
(Lee et al. 2016). So the delayed inhibition of expression of multiple inflammation - related
proteins by the GAIT complex suggests that this system represent a post-transcriptional
off - switch that also contributes to inflammation - resolution. The other group that showed
altered expression consists of small Cajal body - Specific RNAs (scaRNAs), a sub - group
of snoRNAs associated to Cajal body. Cajal bodies, distinct sub - domains of interphase
nucleus, represent specific and dynamic assemblies of proteins and RNA factors involved
in various aspect of gene expression, such the biogenesis and/or transport of small nuclear
ribonucleoproteins (snRNP) and small nucleolar ribonucleoproteins (snoRNPs) (Darzacq
et al. 2002). It was seen that U85 (over - expressed through our experiment) is able to realize
the 2’-O-methylation and psudouridylation of snRNA U5, while U89 and U91 (also over -
expressed in our results) could direct post - transcriptional modification of pol II - specific
spliceosomal snRNAs, as well as U91 (the only scaRNA over - expressed in our analysis).
Following this data, we could speculate that the overall down - regulation of found scaRNAs
could impair specific modifications controlled by them, leading the spliceosome to function
properly.
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5. Conclusions
We realized whole RNA - Seq of two group of RPE cells, treated with oxLDL and
untreated, respectively, comparing miRNAs expression changes in four selected time points
(1h, 2h, 4h, 6h) over time zero. We found that 84 snoRNAs exhibited expression alterations
in treated samples, targeting ribosomal RNA and with host genes involved in several
biochemical pathways. One of them, regarding the GAIT mediated translational silencing
of ceruloplasmin expression, might be associated for the first time to RP etiopathogenesis.
Nevertheless, many other important aspects have to be investigated. Predicted snoRNAs
targets resulted from in silico analyses and, even if they are based on statistical significant
algorithms and literature data, they will be experimentally validated. Furthermore, a deeper
transcriptome sequencing on a larger number of samples could permit us to increase the
number of detected snoRNAs, improving the knowledge on regulative functions of these
small RNAs and RP.
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